YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
4 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
12 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
26 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
52 | -0.3942 | -62.9712460064 | 0.626 | 0.6708 | 0.2 | 46566 | 0.44122809 | CS |
156 | -308.5682 | -99.9249352332 | 308.8 | 363.2 | 0.2 | 1553405 | 15.71899811 | CS |
260 | -32.5122 | -99.2920840459 | 32.744 | 1060 | 0.2 | 1159924 | 70.72497266 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.